175 related articles for article (PubMed ID: 11728685)
1. Effective palliative radiation therapy in advanced and recurrent ovarian carcinoma.
Tinger A; Waldron T; Peluso N; Katin MJ; Dosoretz DE; Blitzer PH; Rubenstein JH; Garton GR; Nakfoor BA; Patrice SJ; Chuang L; Orr JW
Int J Radiat Oncol Biol Phys; 2001 Dec; 51(5):1256-63. PubMed ID: 11728685
[TBL] [Abstract][Full Text] [Related]
2. Recurrent ovarian cancer. Effective radiotherapeutic palliation after chemotherapy failure.
Corn BW; Lanciano RM; Boente M; Hunter WM; Ladazack J; Ozols RF
Cancer; 1994 Dec; 74(11):2979-83. PubMed ID: 7525039
[TBL] [Abstract][Full Text] [Related]
3. Whole abdominopelvic radiotherapy using intensity-modulated arc therapy in the palliative treatment of chemotherapy-resistant ovarian cancer with bulky peritoneal disease: a single-institution experience.
De Meerleer G; Vandecasteele K; Ost P; Delrue L; Denys H; Makar A; Speleers B; Van Belle S; Van den Broecke R; Fonteyne V; De Neve W
Int J Radiat Oncol Biol Phys; 2011 Mar; 79(3):775-81. PubMed ID: 20421155
[TBL] [Abstract][Full Text] [Related]
4. Selective irradiation for the treatment of recurrent ovarian carcinoma involving the vagina or rectum.
Firat S; Erickson B
Gynecol Oncol; 2001 Feb; 80(2):213-20. PubMed ID: 11161862
[TBL] [Abstract][Full Text] [Related]
5. High-dose whole abdominal and pelvic irradiation for treatment of ovarian carcinoma: long-term toxicity and outcomes.
Firat S; Murray K; Erickson B
Int J Radiat Oncol Biol Phys; 2003 Sep; 57(1):201-7. PubMed ID: 12909234
[TBL] [Abstract][Full Text] [Related]
6. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
7. Whole abdominal radiotherapy following second-look laparotomy for ovarian carcinoma.
MacGibbon A; Bucci J; MacLeod C; Solomon J; Dalrymple C; Firth I; Carter J
Gynecol Oncol; 1999 Oct; 75(1):62-7. PubMed ID: 10502427
[TBL] [Abstract][Full Text] [Related]
8. Palliative Radiation Therapy for Recurrent Ovarian Cancer: Efficacy and Predictors of Clinical Response.
Jiang G; Balboni T; Taylor A; Liu J; Lee LJ
Int J Gynecol Cancer; 2018 Jan; 28(1):43-50. PubMed ID: 29040187
[TBL] [Abstract][Full Text] [Related]
9. Radiation therapy in stage III ovarian cancer following surgery and chemotherapy: prognostic factors, patterns of relapse, and toxicity: a preliminary report.
Arian-Schad KS; Kapp DS; Hackl A; Juettner FM; Leitner H; Porsch G; Lahousen M; Pickel H
Gynecol Oncol; 1990 Oct; 39(1):47-55. PubMed ID: 2227572
[TBL] [Abstract][Full Text] [Related]
10. Radiotherapy for isolated recurrent epithelial ovarian cancer: A single institutional experience.
Komura N; Mabuchi S; Isohashi F; Yokoi E; Shimura K; Matsumoto Y; Kodama M; Tomimatsu T; Ogawa K; Kimura T
J Obstet Gynaecol Res; 2019 Jun; 45(6):1173-1182. PubMed ID: 30843318
[TBL] [Abstract][Full Text] [Related]
11. The role of palliative radiation therapy in symptomatic locally advanced gastric cancer.
Tey J; Back MF; Shakespeare TP; Mukherjee RK; Lu JJ; Lee KM; Wong LC; Leong CN; Zhu M
Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):385-8. PubMed ID: 17118569
[TBL] [Abstract][Full Text] [Related]
12. Radiation therapy for consolidation of metastatic or recurrent sarcomas in children treated with intensive chemotherapy and stem cell rescue. A feasibility study.
Czyzewski EA; Goldman S; Mundt AJ; Nachman J; Rubin C; Hallahan DE
Int J Radiat Oncol Biol Phys; 1999 Jun; 44(3):569-77. PubMed ID: 10348286
[TBL] [Abstract][Full Text] [Related]
13. Effective palliative radiotherapy for symptomatic recurrent or residual ovarian cancer.
E C; Quon M; Gallant V; Samant R
Gynecol Oncol; 2006 Aug; 102(2):204-9. PubMed ID: 16427685
[TBL] [Abstract][Full Text] [Related]
14. Treatment of locally recurrent rectal carcinoma--results and prognostic factors.
Wong CS; Cummings BJ; Brierley JD; Catton CN; McLean M; Catton P; Hao Y
Int J Radiat Oncol Biol Phys; 1998 Jan; 40(2):427-35. PubMed ID: 9457832
[TBL] [Abstract][Full Text] [Related]
15. Toxicity of abdominopelvic radiation in advanced ovarian carcinoma patients after cisplatin/cyclophosphamide therapy and second-look laparotomy.
Shelley WE; Starreveld AA; Carmichael JA; O'Connell G; Roy M; Swenerton K
Obstet Gynecol; 1988 Mar; 71(3 Pt 1):327-32. PubMed ID: 3347416
[TBL] [Abstract][Full Text] [Related]
16. Stage III ovarian carcinoma: an analysis of treatment results and complications following hyperfractionated abdominopelvic irradiation for salvage.
Fein DA; Morgan LS; Marcus RB; Mendenhall WM; Sombeck MD; Freeman DE; Million RR
Int J Radiat Oncol Biol Phys; 1994 Apr; 29(1):169-76. PubMed ID: 8175425
[TBL] [Abstract][Full Text] [Related]
17. Local-regional control of recurrent breast carcinoma after mastectomy: does hyperfractionated accelerated radiotherapy improve local control?
Ballo MT; Strom EA; Prost H; Singletary SE; Theriault RL; Buchholz TA; McNeese MD
Int J Radiat Oncol Biol Phys; 1999 Apr; 44(1):105-12. PubMed ID: 10219802
[TBL] [Abstract][Full Text] [Related]
18. Palliative radiation therapy of symptomatic recurrent bladder cancer.
Yi SK; Yoder M; Zaner K; Hirsch AE
Pain Physician; 2007 Mar; 10(2):285-90. PubMed ID: 17387350
[TBL] [Abstract][Full Text] [Related]
19. Chemotherapy, early surgical reassessment, and hyperfractionated abdominal radiotherapy in stage III ovarian cancer: results of a gynecologic oncology group study.
Randall ME; Barrett RJ; Spirtos NM; Chalas E; Homesley HD; Lentz SL; Hanna M
Int J Radiat Oncol Biol Phys; 1996 Jan; 34(1):139-47. PubMed ID: 12118543
[TBL] [Abstract][Full Text] [Related]
20. Superior vena cava obstruction in small-cell lung cancer.
Chan RH; Dar AR; Yu E; Stitt LW; Whiston F; Truong P; Vincent MD; Kocha WI
Int J Radiat Oncol Biol Phys; 1997 Jun; 38(3):513-20. PubMed ID: 9231674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
